Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 31.05m |
Free float | 26.49m |
P/E (TTM) | -- |
Market cap | 404.57m USD |
EPS (TTM) | -99.94 USD |
--
More ▼
Press releases
- GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)
- Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
- GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
- GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update
- Wheels Up Announces Gregory Summe to Join Board of Directors
- GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population
- GRAIL Advances the Galleri® Registrational Clinical Trial Program
More ▼